HIT Stock Risk & Deep Value Analysis
Health In Tech Inc
Technology • Software - Application
DVR Score
out of 10
What You Need to Know About HIT Stock
We analyzed Health In Tech Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran HIT through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
HIT Risk Analysis & Red Flags
Risk Matrix
Overall
Aggressive
Financial
High
Market
Medium
Competitive
High
Execution
High
Regulatory
High
Upcoming Risk Events
- 📅
Slower than expected conversion of pilot programs to paid contracts
- 📅
Competitor launching a similar or superior AI-driven platform
- 📅
Regulatory changes impacting data privacy or AI usage in healthcare
- 📅
Higher than anticipated cash burn leading to further dilution
Unlock HIT Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does Health In Tech Inc (HIT) Do?
Market Cap
$105.28M
Sector
Technology
Industry
Software - Application
Employees
73
Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
Visit Health In Tech Inc WebsiteInvestment Thesis
Health In Tech is a high-conviction, high-risk play positioned to leverage advanced AI to revolutionize preventive healthcare. By achieving superior health outcomes through personalized care, HIT aims to capture significant market share via major enterprise contracts and establish a defensible data moat, driving a potential 10x return within 3-5 years as it scales within a massive, growing digital health market.
Is HIT Stock Undervalued?
Unlock the full AI analysis for HIT
Get the complete DVR score, risk analysis, and more
HIT Price Targets & Strategy
12-Month Target
$4.50
Bull Case
$18.00
Bear Case
$0.80
Entry Strategy
Dollar-cost average between $1.60-$2.00, focusing on accumulation during periods of consolidation or minor pullbacks.
Exit Strategy
Take 25% profit at $5.00, another 25% at $10.00, and hold the remaining for potential $18.00+. Set a stop loss at $1.20 to protect capital.
Portfolio Allocation
5% for aggressive risk tolerance; not suitable for conservative portfolios due to high volatility and early-stage risks.
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Is HIT Financially Healthy?
Valuation
P/E Ratio
92.50
Price/Book
6.09
Does HIT Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Expanding
Moat Sources
3 Identified
The moat's durability hinges on HIT's ability to continuously improve its AI models with proprietary data, secure patents, and integrate deeply into healthcare workflows, making it difficult for competitors to replicate the personalized experience and data advantage.
Moat Erosion Risks
- •Competitor development of equally effective or superior AI solutions
- •Lack of sufficient data to train and refine AI models effectively
- •Regulatory changes restricting data collection or usage
HIT Competitive Moat Analysis
Sign up to see competitive advantages
HIT Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Bullish
Institutional Sentiment
Neutral
Insider Activity (Form 4)
Moderate insider buying activity reported in late 2025, signaling conviction at lower prices. No significant selling.
Options Flow
Limited options activity due to small market cap. Any significant volume would be highly indicative but is currently not prevalent.
Earnings Intelligence
Next Earnings
Estimated early-May 2026 (for Q1 2026)
Surprise Probability
Medium
Historical Earnings Pattern
As an early-stage company, historical earnings reactions are volatile and largely driven by guidance on customer acquisition, cash burn, and strategic partnerships rather than traditional profitability metrics.
Key Metrics to Watch
Competitive Position
Top Competitor
TDOC
Market Share Trend
Gaining
Valuation vs Peers
HIT trades at a significant discount to established digital health peers like Teladoc (TDOC) on traditional revenue multiples (e.g., EV/Sales) given its earlier stage and pre-profitability. Its current valuation is primarily based on future growth potential and market disruption.
Competitive Advantages
- •Proprietary AI-driven personalized preventive care technology
- •Focus on proactive health outcomes rather than reactive treatment
- •Potential for a strong data moat from early pilot program engagement
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive HIT Stock Higher?
Near-Term (0-6 months)
- •Expansion of existing pilot programs (Q2 2026)
- •Announcement of Letters of Intent (LOI) or Memoranda of Understanding (MOU) with initial enterprise clients (Q2-Q3 2026)
Medium-Term (6-18 months)
- •First major enterprise contract signing (Q4 2026 - Q1 2027)
- •Publication of initial clinical validation study results (H1 2027)
- •Announcement of strategic partnerships with healthcare providers or insurers (H2 2027)
Long-Term (18+ months)
- •Broad market adoption and significant market share capture in personalized preventive care (2028+)
- •Establishment of a robust, defensible data moat through aggregated patient insights (2028+)
- •Expansion into international markets (2029+)
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for HIT?
- ✓
Acceleration in the conversion rate of pilot programs to signed enterprise contracts
- ✓
Positive clinical trial results demonstrating improved patient outcomes and cost savings
- ✓
Significant reduction in quarterly cash burn rate or positive free cash flow indication
Bull Case Analysis
See what could go right with Premium
Competing with HIT
See how Health In Tech Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
Health In Tech Inc HIT | $105.3M | 8.0 | 92.5 | — | — | — | |
Apple Inc AAPL | $3730.0T | 1.4 | 32.1 | $391.0B | 0.0% | 0.0% | Compare → |
Alphabet Inc GOOGL | $3570.0T | 1.0 | 27.1 | — | 0.0% | 0.0% | Compare → |
Microsoft Corp MSFT | — | 0.5 | — | — | — | — | Compare → |
NVIDIA Corp NVDA | — | 5.3 | — | — | — | — | Compare → |
Teladoc Health Inc TDOC | — | 5.9 | — | — | — | — | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
FAQ
What is the DVR Score for Health In Tech Inc (HIT)?
As of March 15, 2026, Health In Tech Inc has a DVR Score of 8.0 out of 10, placing it in the "Hidden Gem" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Health In Tech Inc?
Health In Tech Inc's market capitalization is approximately $105.3M. The company operates in the Technology sector within the Software - Application industry.
What ticker symbol does Health In Tech Inc use?
HIT is the ticker symbol for Health In Tech Inc. The company trades on the NCM.
What is the risk level for HIT stock?
Our analysis rates Health In Tech Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of HIT?
Health In Tech Inc currently has a price-to-earnings (P/E) ratio of 92.5. This is above the market average, suggesting the stock may be priced for high growth expectations.
How often is the HIT DVR analysis updated?
Our AI-powered analysis of Health In Tech Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 15, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for HIT (Health In Tech Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.